BR9809628A - Processos para preparação de um composto e para a preparação de um aminoálcool. - Google Patents

Processos para preparação de um composto e para a preparação de um aminoálcool.

Info

Publication number
BR9809628A
BR9809628A BR9809628-1A BR9809628A BR9809628A BR 9809628 A BR9809628 A BR 9809628A BR 9809628 A BR9809628 A BR 9809628A BR 9809628 A BR9809628 A BR 9809628A
Authority
BR
Brazil
Prior art keywords
preparation
processes
compound
amino alcohol
trifluoromethyl
Prior art date
Application number
BR9809628-1A
Other languages
English (en)
Inventor
Richard D Tillyer
Cheng Yi Chen
Lushi Tan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9711599A external-priority patent/GB9711599D0/en
Priority claimed from GB9727129A external-priority patent/GB9727129D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BR9809628A publication Critical patent/BR9809628A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSOS PARA PREPARAçãO DE UM COMPOSTO E PARA A PREPARAçãO DE UM AMINOáLCOOL". Um processo eficiente para a preparação de intermediário chave na síntese de (-)-6-cloro-4-ciclopropiletinil-4-trifluorometil-1,4-diidro-2H-3,1-benzoxa zin-2-ona, um inibidor de transcriptase reversa, é alcançado usando uma reação de adição quiral a 4-cloro-2-trifluorometilcetoanilina com um complexo organozinco, para fornecer o desejado álcool. Este processo atual tem larga aplicabilidade na adição quiral a uma cetona proquiral.
BR9809628-1A 1997-05-16 1998-05-12 Processos para preparação de um composto e para a preparação de um aminoálcool. BR9809628A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4671397P 1997-05-16 1997-05-16
GB9711599A GB9711599D0 (en) 1997-06-05 1997-06-05 Efficient enatioselective addition reation using an organozinc reagent
US5788497P 1997-09-03 1997-09-03
GB9727129A GB9727129D0 (en) 1997-12-22 1997-12-22 Efficient enantioselective addition reaction using an organozinc reagent
US8352598P 1998-04-29 1998-04-29
PCT/US1998/008888 WO1998051676A1 (en) 1997-05-16 1998-05-12 Efficient enantioselective addition reaction using an organozinc reagent

Publications (1)

Publication Number Publication Date
BR9809628A true BR9809628A (pt) 2000-07-04

Family

ID=27547294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809628-1A BR9809628A (pt) 1997-05-16 1998-05-12 Processos para preparação de um composto e para a preparação de um aminoálcool.

Country Status (26)

Country Link
US (1) US6015926A (pt)
EP (1) EP0981520B1 (pt)
JP (1) JP3273615B2 (pt)
KR (1) KR100566683B1 (pt)
CN (1) CN1106389C (pt)
AR (1) AR011731A1 (pt)
AT (1) ATE270666T1 (pt)
AU (1) AU739250B2 (pt)
BR (1) BR9809628A (pt)
CA (1) CA2289206C (pt)
CZ (1) CZ297968B6 (pt)
DE (1) DE69824958T2 (pt)
DK (1) DK0981520T3 (pt)
EA (1) EA002192B1 (pt)
ES (1) ES2224396T3 (pt)
HR (1) HRP980266B1 (pt)
HU (1) HU226881B1 (pt)
NZ (1) NZ500526A (pt)
PL (1) PL193448B1 (pt)
PT (1) PT981520E (pt)
RS (1) RS49860B (pt)
SI (1) SI0981520T1 (pt)
SK (1) SK285446B6 (pt)
TW (1) TWI221833B (pt)
UA (1) UA59396C2 (pt)
WO (1) WO1998051676A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201158B1 (en) * 1998-06-22 2001-03-13 Merck & Co., Inc. Process for making intermediate aldehydes
JP5039541B2 (ja) 2004-04-27 2012-10-03 ワイス・エルエルシー プロゲステロン受容体調節剤の精製
US20090163601A1 (en) * 2007-12-21 2009-06-25 The Regents Of The University Of California (r)-2-methyl-(2,5-dimethylphenyl)propanol and (s)-(2-methyl-2,5-dimethylphenyl)propanol
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
ZA200806473B (en) * 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
US20110071287A1 (en) * 2008-05-01 2011-03-24 Ranbaxy Laboratories Limited Process for the preparation of efavirenz
WO2010032259A2 (en) 2008-05-30 2010-03-25 Emcure Pharmaceuticals Limited Novel process
KR100878436B1 (ko) * 2008-08-18 2009-01-13 주식회사 지씨에이치앤피 금은화 추출물을 포함하는 소화성 궤양 치료 또는 예방용 약학조성물
EP2417114A1 (en) * 2009-04-09 2012-02-15 Lonza Ltd. Process for the synthesis of chiral cyclic carbamates
WO2010115640A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of cyclic carbamates
US8115032B2 (en) * 2009-04-09 2012-02-14 Lonza Ltd. Process for the synthesis of a propargylic alcohol
EP2417097A2 (en) * 2009-04-09 2012-02-15 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
EP2448917A2 (de) 2009-07-03 2012-05-09 Archimica GmbH Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
EP2441759A1 (en) 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447247A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
WO2012079235A1 (en) * 2010-12-16 2012-06-21 Lonza Ltd Process for preparing efavirenz
CN103254087B (zh) * 2013-06-07 2015-03-18 郑州大学 依非韦伦中间体的制备方法
CN105330554B (zh) 2015-02-15 2017-07-11 上海迪赛诺药业股份有限公司 手性环丙基乙炔基叔醇类化合物的合成方法
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz
CN106946718A (zh) * 2017-04-27 2017-07-14 武汉工程大学 一种合成依非韦伦中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
WO1998030540A1 (en) * 1997-01-10 1998-07-16 Merck & Co., Inc. Efficient synthesis of a chiral mediator
NZ336510A (en) * 1997-02-05 2001-04-27 Merck & Co Inc Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
HRP980056A2 (en) * 1997-02-12 1998-12-31 Edward J.J: Grabowski Efficient synthesis of a 1,4-dihidro-2h-3,1-benzoxazin-2-one

Also Published As

Publication number Publication date
SK156299A3 (en) 2000-07-11
RS49860B (sr) 2008-08-07
HRP980266A2 (en) 1999-02-28
PL193448B1 (pl) 2007-02-28
NZ500526A (en) 2001-07-27
EA002192B1 (ru) 2002-02-28
EP0981520A1 (en) 2000-03-01
EP0981520B1 (en) 2004-07-07
HUP0003404A2 (hu) 2000-12-28
HUP0003404A3 (en) 2003-06-30
CZ404699A3 (cs) 2000-07-12
US6015926A (en) 2000-01-18
JP2000513746A (ja) 2000-10-17
CN1106389C (zh) 2003-04-23
TWI221833B (en) 2004-10-11
AU739250B2 (en) 2001-10-04
HU226881B1 (en) 2010-01-28
YU58299A (sh) 2001-12-26
AU7470798A (en) 1998-12-08
SI0981520T1 (en) 2004-10-31
SK285446B6 (sk) 2007-01-04
WO1998051676A1 (en) 1998-11-19
CA2289206C (en) 2008-02-05
CA2289206A1 (en) 1998-11-19
KR100566683B1 (ko) 2006-04-03
DE69824958T2 (de) 2005-07-14
EA199901040A1 (ru) 2000-04-24
CZ297968B6 (cs) 2007-05-09
ATE270666T1 (de) 2004-07-15
KR20010012650A (ko) 2001-02-26
UA59396C2 (uk) 2003-09-15
ES2224396T3 (es) 2005-03-01
JP3273615B2 (ja) 2002-04-08
PT981520E (pt) 2004-10-29
DK0981520T3 (da) 2004-11-01
CN1255919A (zh) 2000-06-07
DE69824958D1 (de) 2004-08-12
PL336717A1 (en) 2000-07-03
HRP980266B1 (en) 2002-10-31
AR011731A1 (es) 2000-08-30

Similar Documents

Publication Publication Date Title
BR9809628A (pt) Processos para preparação de um composto e para a preparação de um aminoálcool.
PA8464901A1 (es) Procesos para la sintesis de 1,3-dioles
BR0109725A (pt) Composto de tetraciclina substituìdo, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, método para sintetizar um composto de tetraciclina 7- ou 9-substituìdo, e, intermediário reativo
GT199900056A (es) Nuevas dihidropirimidinas
BR9813544A (pt) Adesivo com endurecimento em estágios múltiplos e uso do mesmo na produção de materiais compostos
BRPI9915679B8 (pt) composições e métodos para aumentar a mineralização óssea
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
DK0892780T3 (da) m-Amidinophenylanaloger som faktor Xa-inhibitorer
BR0014157A (pt) Escova
ATE203016T1 (de) Cryptophycine
BR0109188A (pt) Diarilaminas 5-amida substituìdas como inibidores de mex
BR0013248A (pt) Inibidores da adesão celular
BR0008239A (pt) Processo de redução de crescimento de cabelos em mamìferos, uso de um inibidor de proteìna-tirosina quinase, processo de produção de uma composição para inibir o crescimento de cabelo de mamìferos, e, composição usada para inibir crescimento de cabelo em mamìferos
BR0213583A (pt) Processo para preparar um composto de insulina, e, composto de insulina
BR0304213A (pt) Processo para a sìntese industrial de ranelato de estrÈncio e os seus hidratos
BR0212966A (pt) Fosfonita, uso da mesma, complexo de metal de transição, processo para a preparação e uso do mesmo, e, processos para a adição de ácido cianìdrico a uma ligação dupla olefìnica na presença de um catalisador, e para a isomerização de nitrilas orgânicas na presença de um catalisador
BR0110430A (pt) Processo para a preparação de um composto, composto, e, uso do mesmo
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
BR0007638A (pt) Processo para determinação pós-genÈmica de estruturas atÈmicas macromoleculares
BR9807761A (pt) oscópicos de l(-)carnitina
ES2172967T3 (es) Metilciclotetradec-5-en-1-ona.
CO5080758A1 (es) DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL
PA8519801A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
BR0211425A (pt) Método para a preparação de compostos, e, uso de uma composição
EA199900277A2 (ru) Способ алкилирования затрудненных сульфонамидов

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PARECER ANTERIOR, DE ACORDO COM O ARTIGO 37 COM BASE NOS ARTIGOS 8O E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.